| Advantages | They preserve hallmark features of ovarian cancer, including genetic mutations and protein expression profiles, positioning them as dependable models for oncology research. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Ovary |
| Disease | Ovarian Cancer |
| Organoid Characterization | Ovarian cancer organoids display high pathological similarity to tumor tissues, with expression of key markers including CA125, HE4, PAX8, and WT1. |
| Applications | Their ability to sustain tumor heterogeneity and emulate the tumor microenvironment (TME) provides a powerful platform for studying disease evolution and therapeutic responses. These physiologically relevant organoids play a pivotal role in precision medicine and the advancement of next-generation ovarian cancer treatments. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.